BMC Infectious Diseases

SEP 4, 2026 · JOURNAL ARTICLE

Clinical utility of nanopore amplicon sequencing in various culture-negative infectious diseases: a case series report

BMC Infectious Diseases

A small, uncontrolled case series without comparator demonstrating feasibility of nanopore sequencing in culture-negative infections, lacking power to establish clinical efficacy or change practice.

SEP 3, 2026 · JOURNAL ARTICLE

Infectious diseases clinical pharmacist-led post-prescription review and therapeutic appropriateness in community-acquired pneumonia: an interrupted time-series study in the United Arab Emirates

BMC Infectious Diseases

A rigorous single-center interrupted time-series study with a large effect size and sustained improvement in a clinically relevant surrogate endpoint, but limited generalizability and requiring multicenter confirmation.

SEP 2, 2026 · JOURNAL ARTICLE

Burden of latent tuberculosis infection among people living with HIV in Shanghai, China: a 4-year cohort study

BMC Infectious Diseases

A single-centre observational cohort study with low event rates (one active TB case) and indeterminate IGRA results limiting clinical inference; provides local epidemiological data but insufficient power to establish a screening algorithm or guide practice change.

AUG 27, 2026 · JOURNAL ARTICLE

Impact of time to positive blood culture on mortality in intensive care unit patients with bacteremia: a retrospective cohort study

BMC Infectious Diseases

Retrospective cohort study of 166 ICU patients confirming that rapid time-to-positivity in blood cultures may serve as a marker of illness severity and bacterial burden, though the mortality difference (47% vs 39%, p=0.292) was not statistically significant.

AUG 25, 2026 · JOURNAL ARTICLE

A matter of time: impact of time to first follow-up blood cultures in patients with candidemia and Staphylococcus aureus bacteremia from a retrospective cohort

BMC Infectious Diseases

A retrospective cohort study with clear associations between timing of follow-up blood cultures and outcomes (length of treatment, time to culture clearance, and survival in Cox regression), but limited by single-centre design, retrospective conduct, and modest effect sizes that require confirmation in prospective studies.

AUG 17, 2026 · JOURNAL ARTICLE

Clinical characteristics and outcomes of left ventricular assist device (LVAD) infections: Could driveline infections be a predictor of deep-seated infections?

BMC Infectious Diseases

Single-centre retrospective cohort study with modest sample size (50 patients, 21 with infections) identifying clinical associations with deep-seated LVAD infection but lacking prospective validation, control group, or adjustment for confounders.

AUG 4, 2026 · REVIEW

Environmental antimicrobial resistance and human infectious disease outcomes: a global one health systematic review and meta-analysis of observational studies

BMC Infectious Diseases

Systematic review and meta-analysis of 32 observational studies showing a consistent, statistically significant pooled association (OR 1.92, 95% CI 1.55–2.38, p<0.001) between environmental AMR and human infectious disease outcomes across multiple regions, though causality is not established.

AUG 4, 2026 · JOURNAL ARTICLE

Intracerebral nodular involvement in neurobrucellosis: case report and review of the literature

BMC Infectious Diseases

A single case report describing a rare manifestation of neurobrucellosis with clinical and radiological follow-up, raising diagnostic awareness rather than testing a hypothesis or providing generalizable evidence.